Founded Year




Total Raised


Date of IPO


Market Cap


Stock Price




About iRhythm Technologies

iRhythm is a healthcare information services company that provides management of cardiac arrhythmia information. Its flagship solution, the ZIO Service, offers an approach to long-term continuous monitoring that enables diagnosis earlier in the clinical pathway to improve patient outcomes and reduce healthcare costs.

iRhythm Technologies Headquarter Location

699 8th St. Suite 600

San Francisco, California, 94103,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing iRhythm Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

iRhythm Technologies is included in 5 Expert Collections, including Medical Devices.


Medical Devices

11,780 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

3,694 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Digital Health

12,800 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)



2,800 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.


Health IT

8,873 items

iRhythm Technologies Patents

iRhythm Technologies has filed 33 patents.

The 3 most popular patent topics include:

  • Cardiac arrhythmia
  • Cardiac electrophysiology
  • Cardiology
patents chart

Application Date

Grant Date


Related Topics




Cardiac arrhythmia, Cardiac electrophysiology, Cardiology, Summary statistics, Causes of death


Application Date


Grant Date



Related Topics

Cardiac arrhythmia, Cardiac electrophysiology, Cardiology, Summary statistics, Causes of death



Latest iRhythm Technologies News

Henry Schein hires former Medline veteran to drive ‘One Distribution’ push

May 17, 2022

Elephants are the perfect analogy for surgical robotics, Medtronic (NYSE:MDT) VP of Marketing for Surgical Robotics Mike Stow says. Speaking on the “Road to a robot: Designing technology to address unmet needs & barriers” panel at DeviceTalks Boston last week, Stow explained that elephants are big, taking up a lot of space and that they eat a lot, making… […] More than one year after receiving the first of two federal grand jury subpoenas seeking information about its products and communications with the FDA, iRhythm Technologies has said little publicly about the matter. It would have been easy to miss the San Francisco-based cardiac monitor maker’s initial disclosure last summer. iRhythm (Nasdaq:IRTC) was without a… […] A lot of talk around Dexcom (Nasdaq:DXCM) in the last couple of years has centered around its next-generation G7 continuous glucose monitor. The latest iteration of the company’s CGM platform has already garnered CE mark this year and awaits FDA approval, with some expectations for that to come after the American Diabetes Association’s Scientific Sessions next month. The company also presented… […] A heatwave in Texas took at least six power plants offline Friday, with high temperatures forecasted to blaze throughout this week. A record cold snap in February 2021 took NXP Semiconductors and Samsung chip fabrication facilities offline for weeks, contributing to a global semicondcutor shortage that is still throttling medical device production. There’s no indication… […] Medical device developers and manufacturers like Stryker (NYSE:SYK) are changing how they approach design as digital technology becomes more crucial. Four Stryker executives shared how the Kalamazoo, Michigan–based orthopedic device giant is thinking differently about medical product development and how health care providers and patients will ultimately use them. The DeviceTalks Boston panel of Stryker… […] DermaSensor Inc. — the creator of a handheld, point-and-click device to quickly assess skin lesions for cancer risk — is the winner of the MedTech Innovator Mid-Stage Companies Pitch Event. The Miami-based mid-stage company beat out 1,000 applicants, more than 20 of which competed on-site May 10–11, 2022 at DeviceTalks Boston. DermaSensor walked away with… […] Steris (NYSE:STE) shares ticked up today on fourth-quarter financial results that came in just ahead of the consensus forecast. The infection prevention technology company — headquartered in Dublin, Ireland, and run operationally out of Mentor, Ohio — posted profits of $52.3 million, or 52¢ per share, on sales of $1.2 billion for the three months… […] Lucira Health (Nasdaq: LHDX) today said it has asked the FDA for an emergency use authorization (EUA) for its combination COVID-19 and flu test. Emeryville, California–based Lucira said the at-home test would be available with a prescription to test for SARS-CoV-2, Influenza A and Influenza B. The Nucleic Acid Amplification Test (NAAT) platform has a… […] AcuityMD said today it has raised $31 million in Series A funding for its medical device commercialization platform. “With our new funding, we plan to double down on R&D by growing our engineering team from 15 to over 40 over the next year,” AcuityMD co-founder and CEO Michael Monovoukas said in a blog post. “We’ll… […] Rockley Photonics (NYSE:RKLY) announced today that it entered into agreements for an $81.5 million private placement. Participating investors agreed to purchase $81.5 million in convertible senior secured notes (due 2026) and warrants to purchase 26.5 million Rockley ordinary shares at an exercise price of $5 per share, subject to certain anti-dilution adjustments. Warrants purchased in… […]

iRhythm Technologies Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

iRhythm Technologies Rank

  • When was iRhythm Technologies founded?

    iRhythm Technologies was founded in 2006.

  • Where is iRhythm Technologies's headquarters?

    iRhythm Technologies's headquarters is located at 699 8th St., San Francisco.

  • What is iRhythm Technologies's latest funding round?

    iRhythm Technologies's latest funding round is IPO.

  • How much did iRhythm Technologies raise?

    iRhythm Technologies raised a total of $99.03M.

  • Who are iRhythm Technologies's competitors?

    Competitors of iRhythm Technologies include Peerbridge Health, Cardiologs, Bardy Diagnostics, Preventice Solutions, BioTelemetry and 8 more.

  • Who are iRhythm Technologies's customers?

    Customers of iRhythm Technologies include UCSF, Spectrum Health and Scripps Health.

You May Also Like

Happitech Logo

Happitech develops a CE Certified heart rhythm SDK for Android & iOS. Once integrated into an application, the company's algorithms allow medical-grade vital signs monitoring directly through a smartphone.

Peerbridge Health

Peerbridge Health develops wearable wireless vital sign monitoring technology. The company's medical grade information transforms the way doctors and consumers communicate their health information.

Eko Logo

Eko creates digital health solutions including AI-enabled stethoscopes, patient and provider software, and AI-powered analytics that enable doctors, nurses, researchers, and entire health systems to change care for the heart.

InfoBionic Logo

InfoBionic is a digital health company focused on creating patient monitoring solutions for chronic disease management with an initial market focus on cardiac arrhythmias. InfoBionic's lead product, MoMe® Kardia, is a remote cardiac arrhythmia detection and monitoring system that replicates in-hospital telemetry data, right in the office, by giving physicians 24/7 on-demand access to full disclosure Holter, Event, and MCT data via a HIPAA-compliant portal app.

Powerful Medical Logo
Powerful Medical

Powerful Medical is a deep-tech company, tackling the most challenging opportunities of modern medicine with AI and other innovative technologies. The company's core product is an AI-powered clinical assistant aiding doctors with the diagnosis and personalized treatment of cardiovascular diseases.

Spacelabs Healthcare Logo
Spacelabs Healthcare

Spacelabs Healthcare is a developer of medical devices that provide tools for the clinician and the best care experience for their patients.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.